Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
SAMDAILY.US - ISSUE OF OCTOBER 31, 2021 SAM #7274
SOLICITATION NOTICE

R -- Biological Therapeutics Product Development Subject Matter Expert Consulting Services to Support the Development of Therapeutic Biotechnology Products (Biologics)

Notice Date
10/29/2021 3:06:54 PM
 
Notice Type
Combined Synopsis/Solicitation
 
NAICS
541690 — Other Scientific and Technical Consulting Services
 
Contracting Office
NATIONAL INSTITUTES OF HEALTH NIDA Bethesda MD 20892 USA
 
ZIP Code
20892
 
Solicitation Number
NIH-NINDS-CSS-22-000015
 
Response Due
11/12/2021 3:00:00 PM
 
Archive Date
11/27/2021
 
Point of Contact
Evan Feely, Phone: 301.827.5301, Nancy Lamon-Kritikos, Phone: 301.480.2447
 
E-Mail Address
evan.feely@nih.gov, nancy.lamon-kritikos@nih.gov
(evan.feely@nih.gov, nancy.lamon-kritikos@nih.gov)
 
Small Business Set-Aside
SBA Total Small Business Set-Aside (FAR 19.5)
 
Description
The National Institute of Neurological Disorders and Stroke (NINDS) has a need for biological therapeutics development subject matter expert (SME) consulting services. SME consultants will be required to provide technical recommendations and advice that will support the translational development of novel therapeutics (Biologics) for NIH drug discovery and development programs. Several such programs are being launched or expanded to provide support for investigators developing medical interventions for neurological disorders. These include the NIH Blueprint Neurotherapeutics Network Biologics (BPN-Biologics) program, the NINDS Ultra-Rare Gene Therapy (URGenT) program, the Helping to End Addiction Long-term Pain Therapeutics Development Program (HEAL-PTDP), and other extramural or intramural NIH programs. The SMEs will support these biologics development programs by providing consulting services related to candidate biologics therapeutics development, current Good Manufacturing Practices (cGMP) manufacturing, and evaluation of the biologics in Phase 1 clinical trials. Please review the attachments for additional information.
 
Web Link
SAM.gov Permalink
(https://beta.sam.gov/opp/0af66e8b75714c2dbcbf430d01689576/view)
 
Record
SN06167335-F 20211031/211029230111 (samdaily.us)
 
Source
SAM.gov Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's SAM Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.